Epidemiological, clinical, and laboratory aspects of pertussis in adults

Clinical Infectious Diseases

Volumn 28, Issue 6 SUPPL. 2, 1999, Pages

  Cherry, James D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; PERTUSSIS VACCINE;

BORDETELLA PERTUSSIS; CONFERENCE PAPER; COUGHING; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; GERMANY; INCIDENCE; PERTUSSIS; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; VACCINATION;

EID: 0033012493     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515058     Document Type: Conference Paper

References (36)

1. 1. Linnemann CC, Nasenbeny J. Pertussis in the adult. Annu Rev Med 1977; 28:179-85.
2. 2. Nelson JD. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am J Dis Child 1978;132: 371-3.
3. 3. Linnemann CC, Ramundo N, Perlstein PH, Minton SD. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975;2:540-1.
4. 4. Kurt TL, Yeager AS, Guenette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972;221:264-7.
5. 5. Pertussis in adults. Br Med J 1972;4:316-7.
6. 6. Morse SI. Pertussis in adults. Ann Intern Med 1968;68:953-4.
7. 7. Burstyn DG, Baraff LJ, Peppler MS, Leake RD, St Geme J Jr, Manclark CR. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun 1983;41: 1150-6.
8. 8. Cherry JD, Baraff LJ, Hewlett E. The past, present, and future of pertussis: the role of adults in epidemiology and future control. West J Med 1989; 150:319-28.
9. 9. Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust 1987;147:522-5.
10. 10. Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14:464-71.
11. 11. Schmitt-Grohé S, Cherry JD, Heininger U, Überall MA, Pineda E, Stehr K, Pertussis in German adults. Clin Infect Dis 1995;21:860-6.
12. 12. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995;346:1326-9.
13. 13. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995;273:1044-6.
14. 14. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 1995;171:1650-2.
15. 15. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-4.
16. 16. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984;14:7-77.
17. 17. Cherry JD, Brunell PA, Golden GS, Karzon DT. Report of the task force on pertussis and pertussis immunization-1988. Pediatrics 1988; 81(suppl):939-84.
18. 18 Fine PEM, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1982;1:666-9.
19. 19. Cherry JD, Beer T, Chartrand SA, et al. Comparison of values of antibody to Bordetella pertussis antigens in young German and American men. Clin Infect Dis 1995;20:1271-4.
20. 20. Deville JG, Cherry JD, Christenson PD, et al. Frequency of unrecognized Burdetella pertussis infections in adults. Clin Infect Dis 1995;21: 639-42.
21. 21. Deen JL, Mink CM, Cherry JD, et al. A household contact study of Bordetella pertussis infections. Clin Infect Dis 1995;21:1211-9.
22. 22. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996;174(suppl 3):S259-63.
23. 23. Stehr K, Cherry JD, Heininger U, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 1998;101:1-11.
24. 24. Cromer BA, Boydos J, Hackell J, Mezzatesta J, Dekker C, Mortimer EA. Unrecognized pertussis infection in adolescents. Am J Dis Child 1993; 147:575-7.
25. 25. Fine PEM, Adult pertussis: a salesman's dream-and an epidemiologist's nightmare. Biologicals 1997;25:195-8.
26. 26. Barenkamp SJ, Leininger E. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect Immun 1992;60: 1302-13.
27. 27. Postels-Multani S, Schmitt HJ, Wirsing von König CH, Bock HL, Bogaerts H. Symptoms and complications of pertussis in adults. Infection 1995; 23:139-42.
28. 28. Musher DM, Keitel W. Severe paroxysmal coughing and pleuritic pain in an adult, Hosp Pract 1995;30:65-7.
29. 29. Centers for Disease Control and Prevention. Pertussis-United States, January 1992 June 1995. MMWR Morb Mortal Wkly Rep 1995;44: 525-9.
30. 30. Centers for Disease Control and Prevention. Pertussis outbreak - Vermont, 1998. MMWR Morb Mortal Wkly Rep 1997;46:822-6.
31. 31. Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 1994;13:343-5.
32. 32. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 1997;16(suppl): S85-9.
33. 33. Cherry JD. Introduction. Pediatr Infect Dis J 1997;16(suppl):S76-7.
34. 34. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999;28(suppl 2):000-0.
35. 35. Greco D, Salmaso S, Mastrantonio P. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.
36. 36. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334:349-55.